http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016069542-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc62792656aa2e858252e97e5ffaca79
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-12
filingDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50222c83571c35042a46323fc666706c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb8317a37489c4ac4d8c4cd3d1a581d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139855824804f2929d7d7c8e40b517a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c5ac967bd9c69f61aaa1be44dfb37f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee556c9ff54ba2f2e13e8ee48b05488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae0579598b4721e309b81ccf36adba1
publicationDate 2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016069542-A3
titleOfInvention Lactone compounds and methods of making and using same
abstract Provided herein are lactone compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as inhibitors of serine hydrolases, such as ABHD16A. Furthermore, the subject compounds and compositions may be useful for the treatment of, for example, PHARC and other neuroinflammatory diseases.
priorityDate 2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013177492-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006258620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013083724-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID193742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID361796

Total number of triples: 33.